Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD)

This study has been completed.
Sponsor:
Information provided by:
Protalix
ClinicalTrials.gov Identifier:
NCT00258778
First received: November 23, 2005
Last updated: December 4, 2006
Last verified: December 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2006
  Estimated Primary Completion Date: No date given
No publications provided by Protalix

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):